About David Snitman
Form D filings for Ambrosia Biosciences in 2024 list David Snitman as director.
David Snitman reports to the SEC as a director or officer of 1 public company: Array Biopharma (ARRY).
David Snitman first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name David Snitman in the role, so the role may have started earlier or lasted longer.
AI
Array Biopharma Inc.
COO and VP, Business Devel, director
2006 – 2015 · Public company (ARRY)
Key Colleagues at Startups
The people David Snitman works with at each company, as listed on that company's latest Form D.
Ambrosia Biosciences Inc. · Form D/A, Aug 20, 2024
WM
William Marshall
Director
NT
Nicholas Traggis
Executive officer and director
KL
Kyle Lefkoff
Director
JO
John Orwin
Director